the market?
ARCA Biopharma, Inc.
NASDAQ: ABIO
2.66
0.10
(3.91%)
| Today's Open | $2.56 |
|---|---|
| Previous Close | $2.56 |
| Daily Range | $2.50 - $2.70 |
| 52-Week Range | $1.38 - $5.93 |
| Market Cap | $8.5M |
| P/E Ratio | -1.60 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 33,247 |
| Average Daily Volume | 128,515 |
| Current FY EPS | $0.00 |
How do you think ABIO
will perform against the market?
Top ABIO Bull/Bear Pitches
zzlangerhans (< 20)
Submitted
July 30, 2011
I do regret not holding on to my last red thumb on ARCA. After all, the stock was going nowhere and I knew it. But I've lost all my points on red thumbs so many times when the price started shooting b … More
News & Commentary
ARCA Announces Death of Board Member Burton E. Sobel, Preeminent Physician Scientist and Academic Le
Market Close: Big Winners & Losers for March 14, 2013 (ABIO, SSNI, KWK, DYNT, MW, VHC, SCON, VELT, O
Market Close: Big Winners & Losers for March 14, 2013 (ABIO, SSNI, KWK, DYNT, MW, VHC, SCON, VELT, OPTT, VRS)Market Close: Big Winners & Losers for March 13, 2013 (ABIO, SSNI, KWK, DYNT, MW, VHC, SCON, VELT, O
Market Close: Big Winners & Losers for March 13, 2013 (ABIO, SSNI, KWK, DYNT, MW, VHC, SCON, VELT, OPTT, VRS)CEO of ARCA biopharma to Speak on Changing Paradigms in Drug Development at ACC.13 Conference on Mar
Sector
Healthcare
Industry
Drugs
ARCA Biopharma, Inc. (ABIO) Description
ARCA biopharma Inc. is a biopharmaceutical company whose focus is developing genetically-targeted therapies for cardiovascular diseases. Website: http://www.arcabiopharma.com/
